REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Avicenna Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: AVICENNA Gyogyszer es Gyogynoveny Forgalmazo Bt. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Avicenna Bt. is based in Hungary. The head office is in Ofeherto. It operates in the Pharmacies and Drug Stores industry. The enterprise was incorporated on July 11, 1996. It currently has a total number of 3 (2024) employees. From the latest financial highlights, Avicenna Bt. reported a net sales revenue increase of 12.25% in 2023. During that time, Avicenna Bt.’s total assets grew by 10.02%. In 2023, Avicenna Bt.’s net profit margin increased by 0.8%.

Headquarters
Alkotmany u. 14.
Ofeherto; Szabolcs-Szatmar-Bereg; Postal Code: 4558

Contact Details: Purchase the Avicenna Bt. report to view the information.

Basic Information
Total Employees:
Purchase the Avicenna Bt. report to view the information.
Outstanding Shares:
Purchase the Avicenna Bt. report to view the information.
Registered Capital:
Purchase the Avicenna Bt. report to view the information.
Financial Auditors:
Purchase the Avicenna Bt. report to view the information.
Incorporation Date:
July 11, 1996
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Viridis-Pharma Kft.
Company Performance
Financial values in the chart are available after Avicenna Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
12.25%▲
Total operating revenue
10.76%▲
Operating profit (EBIT)
19.9%▲
EBITDA
4.87%▲
Net Profit (Loss) for the Period
21.72%▲
Total assets
10.02%▲
Total equity
13.52%▲
Operating Profit Margin (ROS)
0.72%▲
Net Profit Margin
0.8%▲
Return on Equity (ROE)
4.46%▲
Quick Ratio
0.05%▲
Cash Ratio
0.15%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo